Off the cuff: rebooting blood pressure treatment.
Off the cuff: rebooting blood pressure treatment.
复制标题
即兴:重新启动血压治疗。
DOI:
10.1016/s0140-6736(16)31348-4
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Topol,EricJ
中科院分区:
文献类型:
--
作者:
Steinhubl,StevenR;Muse,EvanD;Barrett,PaddyM;Topol,EricJ
The sphygmomanometer was first introduced into clinical practice some 120 years ago, followed decades later by the concept of high blood pressure as a disease. It took several more decades before antihypertensive medications became available, and today there are nearly a dozen individual classes of blood pressure-lowering drugs. Yet despite having the basic tools necessary to diagnose and treat hypertension for over half a century, high blood pressure remains one of the leading contributors to morbidity and mortality worldwide.There are many reasons for this problem, including the need for better awareness of lifestyle and environmental factors, policies that promote healthy behaviours, and universal access to affordable antihypertensive drugs. Another key issue is that we don't yet have a clear understanding of “normal” blood pressure. This is mainly due to the fairly cumbersome act of cuff-based blood pressure determination, which has mostly relegated blood pressure monitoring to one-off measurements in a clinic. This approach prevents us from understanding night-time versus daytime blood pressure, day-to-day or even minute-to-minute variability, and blood pressure trajectories over years and decades. Additionally, there are inadequate systems of care to enable the identification and proper management of individuals with hypertension or those at high risk. Many people with hypertension globally do not have their blood pressure adequately controlled. This is partly due to the fact that hypertension is undiagnosed in many patients, but also because only about a third of those diagnosed are adequately controlled.